The counterfeit product was found to be sold by Babban Gida Agalawa General Enterprises, a company without a valid NAFDAC registration number. The label on the product was also misleading, which posed a significant risk to public health.
According to NAFDAC, the batch number of the fake product is 0070, with a manufacturing date of January 2, 2024, and an expiration date of January 2, 2027. The manufacturer’s address is listed as No. 883/884 Western Bypass Ring Road, Kumbosto Local Government, Kano State.
To combat the illegal sale of unregistered medicines, NAFDAC has directed its Zonal Directors and State Coordinators to conduct surveillance operations to mop up the fake products within their jurisdictions. Consumers are advised to exercise extreme caution when purchasing medicines and to ensure that products are obtained from authorized and licensed suppliers.
NAFDAC has also urged healthcare professionals and consumers to report any suspicion of the sale of substandard or falsified medicines or medical devices to the nearest NAFDAC office. Additionally, they should report any adverse events or side effects related to the use of medicinal products through NAFDAC’s e-reporting platforms.
The agency’s Director-General, Prof. Mojisola Adeyeye, emphasized that without compliance with regulatory provisions, the safety, quality, and efficacy of such products cannot be guaranteed. She warned that NAFDAC will take swift action against anyone found selling or distributing unregistered medicines.
In light of this development, NAFDAC is urging all stakeholders to remain vigilant and report any suspicious activities or products to ensure that only safe and effective medicines reach the Nigerian market.
